To the Editor: As Olin points out in his review (Sept. 21 issue),1 exposure to tobacco plays a central part in the initiation and progression of thromboangiitis obliterans (Buerger's disease).

Buerger's disease, also known as thromboangiitis obliterans, is a rare condition that primarily affects young to middle-aged male smokers. The veins and arteries of the extremities constrict or ...

To the Editor: The June 9 issue of the Journal contains a thoroughly documented article by Wessler and his coworkers, advocating the elimination of thromboangiitis obliterans as a clinical entity ...

What is Buerger's Disease? Know Symptoms, Causes And Treatment of This Rare Disease. Buerger’s disease, also known as thromboangiitis obliterans, has a striking but poorly understood link to ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to AMB-301 for the treatment of Buerger disease, also known as thromboangiitis obliterans.

Buerger’s disease is also called Thromboangiitis Obliterans and is a rare disease in which the blood vessels of the hands and feet get inflamed or swollen. Doctors reveal all you need to know ...

Buerger’s disease, also known as thromboangiitis obliterans, is a condition related to critical limb ischemia and has no approved treatments in the United States. Source: Adobe Stock.

--Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that the U.S. Food and ...

(Vasospastic PVD, including Buerger's disease [thromboangiitis obliterans] and Raynaud's disease, occurs more commonly in patients younger than 40.) ...

Buerger's disease, also known as thromboangiitis obliterans (TAO), is a non-atherosclerotic, inflammatory occlusive disease that predominantly affects small- and medium-sized arteries and veins of ...